Tag: first-in-human

2 articles

Industry News

Three patients received a 30-minute test of Coherence Neuro's brain-tumor implant at Royal Melbourne Hospital

Coherence Neuro placed its cancer-targeting brain-computer interface in three patients for 30 minutes during brain tumor resection at Royal Melbourne Hospital, with a permanent-implant glioblastoma trial planned for 2027.

Jun 23

Industry News

Phantom Neuro gets green light for first human trial of its subcutaneous prosthetic sensor

The Melbourne-based startup has received FDA approval to begin a first-in-human study of Phantom X, an implanted sensor array that reads neuromuscular signals from a residual limb without entering the nervous system — aiming to give amputees more natural prosthetic control.

Apr 15

Stay Ahead of the Curve

Get the latest BCI news, breakthroughs, and market moves delivered to your inbox.

No spam. One-click unsubscribe. We respect your privacy.